Shimizu et al(7) confirmed that α4GnT, whichforms a unique glycan, GlcNAcα1-->4Galβ-->R, is detectablein 80% of 5 patients with an early stage of gastric cancer and the expression levelof α4GnT mRNA is increased in association with tumor progression. This evidence concerns the gene A4GNT and gastric cancer.